Federal & State

DOCUMENT                               

YEAR

EXCERPT FROM HEARING/DOCUMENT

2001

Purdue Executive statement:

There is widespread consensus that medical practitioners, in the course of their

medical education, have received limited and often inadequate training in the management

of chronic pain.

….. We knew that in order to use these

products properly and responsibly, physicians would need education.

2002

2005

But if we are going to hold Pharma to

the standard of being educational, then their ads need to be held

to the same high standards of educational material in medicine:

WAXMAN:

Now, I look at the documents that we have received and I get

a different picture: the goal is sales, not education.

Glen R. Hanson Testimony (before Cong. Hrg.)

2002

By having our finger on the pulse of these constantly changing drug trends and by having a comprehensive research portfolio that covers all substances of abuse, NIDA is poised to use the power of scientific research and its application to avert emerging drug problems before they become national epidemics

2005

2005

2002

The 1500 physicians that SAMHSA and our partners have trained are in addition to those who may be already qualified by virtue of having been previously certified as addiction treatment specialists by one or more of the organizations specified in the DATA. Although many physicians qualified by previous certification in addiction have also sought the additional eight hours mandated under the DATA for physicians who do not already have such recognized certification.

2003

However, the committee encouraged that DEA licensure to prescribe these products be linked to a requirement for

Continuing Medical Education related to the use of opioids.

…the

Committee felt strongly that requiring education as a condition of opioid prescribing would be a very positive step.

2003

We need to make sure that our healthcare colleagues understand the signs, symptoms and indicators of abuse and how to assess for abuse before putting a person on this medication.

2003

DEA is also working with FDA to encourage state medical

boards to require, as a condition of their state licensing, that physicians

obtain continuing medical education on pain management.

2004

Recognizing the importance of appropriate pain management,

between 1998 and 2001, NASCSA members adopted three different resolutions reiterating their support for the appropriate use of controlled substances and encouraging increased education for practitioners, pharmacists, and other health

care providers surrounding the appropriate use of prescription controlled substances for treating patients with legitimate medical conditions.

CONGRESSIONAL TESTIMONY: MADRAS

2006

ONDCP is also convening a medical conference to assemble leading medical professional associations to focus on medical education on addictions, and specifically on prescription medications.

2006

 Controlled substance education must be mandated in medical schools, residency training programs, pharmacy schools, and supported by continuing education each year variable from 20 hours in the first year and 10 years in the subsequent. The training must be accredited and approved and may be monitored mainly by DEA or State Board of Medical Licensures.

DEA LETTER TO JORANSON

2004

2006

Finally, the DEA has met with the leading certifying medical boards and

encouraged them to develop educational programs concerning the prescribing of

controlled substances, especially high-dose opioids.

2006

The question becomes, “How can so many prescriptions for opioids be written by so many doctors with so little training?

2006

Therefore, physician education is a necessary part of any effort to curb the abuse of prescription medications

2004

continuing our efforts to improve physician education on treatment of pain and recognition of addiction.

JAMES R. MCDONOUGH TESTIMONY

2004

We will also aggressively develop comprehensive education and training opportunities for medical specialists, appropriate people. Doctors need more information on the potency of what they are prescribing, the possible effects of various drugs in combination.

2004

Education also needs to include health care professionals (doctors, pharmacists, nurses, etc.), policy makers, medical licensing boards, other regulators, law enforcement and the public on the appropriate use of pain medications and what constitutes misuse, abuse and addiction. Education needs to include such basics as proper disposal of prescription medicines that are no longer needed. The educational needs are broad, real, and important.

2004

Currently, there is no requirement for demonstration or attestation of knowledge or training in order to maintain DEA registration.

2003

This is why we need doctor education, not to reduce the prescribing, but to make it as intelligent and as clinical as possible.

2003

RE EDUCATION:

Due to time constraints, the committee did not address this aspect of question 3.

2006

DEA, however, has neither the

legal authority nor the expertise to

provide medical training to physicians

or issue guidelines that constitute

advice on the general practice of

medicine.21

For these reasons, DEA is not

proposing any medical guidelines on

prescribing controlled substances for the

treatment of pain.

2008

we realize that education and training are most  useful when complemented by the practical tools necessary

for the day-to-day safe management of

patients on opiate therapy.

LOUISIANA

2002

Adopt a Resolution requiring Licensing Boards of those persons who prescribe or dispense

controlled dangerous substances to include a requirement of continuing medical education

programs addressing proper pain management and addictive disorders.

Doctors don't get medical education, at least my generation of physicians, around management of chronic pain.

2010

214 REFERENCES TO PHYSICIAN “EDUCATION”

2010

236 REFERENCES TO PHYSICIAN “EDUCATION”

We have heard no suggestion that providers 13 found education on these topics intrusive or 14 unwelcomed.

MISSOURI

2001

As of December 2001, no physician education

protocols specific to OxyContin misuse have

been published.